Comparative Benchmarking
In the context of the broader market, BCAB competes directly with industry leaders such as BIVI and PHGE. With a market capitalization of $11.14M, it holds a leading position in the sector. When comparing efficiency, BCAB's gross margin of N/A stands against BIVI's N/A and PHGE's N/A. Such benchmarking helps identify whether Bioatla Inc is trading at a premium or discount relative to its financial performance.